Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Consolidation Provides Free Access to DNA Sequence Information

By LabMedica International staff writers
Posted on 11 Jun 2010
Three major sequence resources have consolidated to become Europe's primary access point to globally concise DNA and RNA sequence data. More...


The European Nucleotide Archive (ENA) is freely available from the European Bioinformatics Institute (EMBL-EBI; Cambridge, UK), a part of European Molecular Biology Laboratory.

Faster and low cost DNA sequencing has led to previously unheard of amounts of data being deposited in the public nucleotide sequence databases: today, ENA holds over 20 terabases of nucleotide sequence which, combined with associated information (annotation), occupies 230 terabytes of disk space. Thoroughly annotated and crosslinked sequence records from the EMBL Nucleotide Sequence Database (EMBL-Bank) form the backbone of the ENA. But significantly, ENA now also provides direct access to raw sequence data: the European Trace Archive contains raw data from electrophoresis-based sequencing machines and was previously maintained at the Wellcome Trust Sanger Institute (Cambridge, UK); the Sequence Read Archive (SRA) is a newly established repository for raw data from next-generation (array-based) sequencing platforms. Improved submission and data-access tools make it easier for ENA's users to share their sequence data.

"Large-scale DNA sequencing was previously the domain of a small number of specialist labs, but next-generation sequencing has made it accessible to the majority of molecular life scientists,” explained Graham Cameron, the EMBL-EBI's associate director. "The launch of ENA reflects our continuing commitment to promoting scientific progress by providing global access to nucleotide sequence information. This has been central to EMBL's mission since the 1980s when we launched the EMBL Data Library.”

Guy Cochrane, who leads the ENA team, stated that "ENA has been designed to provide our users with improved access both to annotated and to raw sequence data through the same user-friendly interface. It provides graphical browsing, web services, text search, and a new rapid sequence similarity search. ENA also provides access to related information, with over 190 million cross references to external records, many of which are in other EMBL-EBI data resources.”

The ENA team plans to launch many new features for the resource over the next twelve months, including enhancements to the user-friendly browser, improved interactive submissions tools, and organism- and project-centered portals into ENA data.

Tim Hubbard, head of informatics at the Wellcome Trust Sanger Institute, said, "As major generators of DNA sequence data, it is important to us that the research community has ready access not only to annotated sequence information, but also to raw data. It's great to see the launch of ENA with new interfaces for users to this vast and rapidly growing body of information.”

Related Links:

European Bioinformatics Institute


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.